Physician

Oncology

Bijoyesh Mookerjee works in the field of Oncology. He went to medical school at Armed Forces Medical College Pune. He over the years received 1 awards: "Patient-Centered Specialty Practice Recognition Program". Bijoyesh Mookerjee is a published MD as well. He has 15 publications published. The latest was: A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.

Publications

---

• A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced Polycythemia vera who are refractory or intolerant to hydroxyurea.
• Biological significance and molecular mechanisms of p53-induced apoptosis.
• Autotransplantation for advanced Lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.
• Overcoming drug resistance: targeting more than one site.
• Salvage therapy for refractory Chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.
• Cediranib monotherapy in patients with advanced renal cell carcinoma: Results of a randomised phase II study.
• A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing.
• Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.
• Adenovirus DNA polymerase is recognized by human CD8+ T cells.
• Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy.
• T cell repertoire complexity is conserved after LLME treatment of donor lymphocyte infusions.
• In vitro methods for generating highly purified EBV associated tumor antigen-specific T cells by using solid phase T cell selection system for immunotherapy.
• Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
• Cytoprotection in Acute myelogenous leukemia (AML) therapy.

Schools

---

• Armed Forces Medical College Maharashtra University Of Health Sciences

• SUNY

• NihNci

Conditions Treated

---

• Acute Leukemia
• Anemia
• Chronic Myeloid Leukemia (CML)
• Myelodysplastic Syndromes
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Patient-Centered Specialty Practice Recognition Program

Education

---

• National Institutes of Health Clinical Center
• SUNY Health Science Center at Brooklyn
• Armed Forces Medical College Pune

Hospital

---

• Thomas Jefferson University Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Lori A. Goldstein, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Elizabeth D. Pulte, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith T. Flaherty, MD This Doctor is OpenDoctor Recommended.
	Dr. Angela Demichele, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Juhi Mittal, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael E. Klein, MD This Doctor is OpenDoctor Recommended.
	Dr. Kara N. Maxwell, MD This Doctor is OpenDoctor Recommended.
	Dr. Brandon E. Kremer, MD This Doctor is OpenDoctor Recommended.
	Dr. Eiko Klimant, MD This Doctor is OpenDoctor Recommended.
	Dr. Roger B. Cohen, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Marlana M. Orloff, MD This Doctor is OpenDoctor Recommended.
	Dr. Reshma Rangwala, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog